Pentixapharm Ag
Clinical trials sponsored by Pentixapharm Ag, explained in plain language.
-
New scan aims to spot hidden lymphoma tumors more accurately
Diagnosis TerminatedThis trial tested a new type of PET scan imaging agent called [68Ga]Ga-PTF to see if it could better detect and map out marginal zone lymphoma tumors compared to the standard FDG PET scan. The study involved patients with confirmed lymphoma who had not yet started treatment. The …
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
Can a brain scan predict Cancer's return?
Knowledge-focused TerminatedThis study aimed to see if a special type of PET scan, using a tracer called [68Ga]Ga-PentixaFor, could predict how well patients with primary or isolated secondary brain lymphoma would respond to chemotherapy. The goal was to check if a scan taken partway through treatment could…
Phase: PHASE2 • Sponsor: Pentixapharm AG • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC